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The Erv41–Erv46 complex serves as a retrograde
receptor to retrieve escaped ER proteins
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S

ignal-dependent sorting of proteins in the early secretory pathway is required for dynamic retention
of endoplasmic reticulum (ER) and Golgi components. In this study, we identify the Erv41–Erv46 complex
as a new retrograde receptor for retrieval of non–HDELbearing ER resident proteins. In cells lacking Erv41–Erv46
function, the ER enzyme glucosidase I (Gls1) was mislocalized and degraded in the vacuole. Biochemical experiments demonstrated that the luminal domain of Gls1
bound to the Erv41–Erv46 complex in a pH-dependent
manner. Moreover, in vivo disturbance of the pH gradient

across membranes by bafilomycin A1 treatment caused
Gls1 mislocalization. Whole cell proteomic analyses of
deletion strains using stable isotope labeling by amino
acids in culture identified other ER resident proteins that depended on the Erv41–Erv46 complex for efficient localization. Our results support a model in which pH-dependent
receptor binding of specific cargo by the Erv41–Erv46
complex in Golgi compartments identifies escaped ER resident proteins for retrieval to the ER in coat protein complex I–formed transport carriers.

Introduction
Newly synthesized secretory proteins are folded and modified
in the ER before transport to Golgi compartments in a coat protein complex II (COPII)–dependent pathway, whereas transport
machinery and escaped ER resident proteins are retrieved from
Golgi compartments back to the ER through a coat protein complex I (COPI)–dependent retrograde pathway (Brandizzi and
Barlowe, 2013). Transported cargo proteins can be selectively
incorporated into COPI- and COPII-coated carrier vesicles
through direct and indirect binding to subunits of these coat
complexes (Cosson and Letourneur, 1994; Kuehn et al., 1998)
or can traffic in a passive bulk-flow manner (Thor et al., 2009).
For selective incorporation of transmembrane proteins, cytoplasmically exposed sorting signals have been identified that
bind to defined recognition sites in COPI and COPII subunits
(Mossessova et al., 2003; Jackson et al., 2012). However, not all
transmembrane proteins that traffic through the early secretory
pathway display known COPI or COPII sorting signals, and a
large number of soluble cargos cannot be directly recognized by
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coat subunits because they are luminally disposed. To efficiently
transport these proteins, a diverse family of sorting receptors
is required to link specific cargo to COPI and COPII coat subunits (Dancourt and Barlowe, 2010). For example, ERGIC53
and Erv14 link soluble and transmembrane secretory cargo
to COPII adaptor subunits for forward transport (Appenzeller
et al., 1999; Powers and Barlowe, 2002), whereas the KDEL
receptor and Rer1 bind soluble and transmembrane cargo to the
COPI coat for retrograde transport from Golgi compartments
(Lewis and Pelham, 1990; Semenza et al., 1990; Sato et al.,
1997). Understanding how coat complexes and cargo receptors
manage the broad spectrum of proteins that must be sorted in
the early secretory pathway and how cargo binding is regulated
remain challenging questions.
Proteomic analyses of purified COPII vesicles identified
the heteromeric Erv41–Erv46 complex as efficiently packaged
ER vesicle proteins that localized to ER and Golgi membranes
(Otte et al., 2001). Erv41 and Erv46 are related integral membrane proteins that each contains two transmembrane segments,
short cytosolic N- and C-terminal regions, and large luminal
domains. Expression of Erv41 and Erv46 are interdependent
© 2015 Shibuya et al. This article is distributed under the terms of an Attribution–Noncommercial–
Share Alike–No Mirror Sites license for the first six months after the publication date (see
http://www.rupress.org/terms). After six months it is available under a Creative Commons
License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at
http://creativecommons.org/licenses/by-nc-sa/3.0/).
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Figure 1. Deletion of ERV41 reduces the cellular levels of Gls1 caused by vacuolar degradation. (A) Cells grown to mid–log phase were
lysed, resolved on a 10.5% polyacrylamide
gel, and immunoblotted for Gls1, CPY, Erv41,
and Yet3 (loading control). WT (CBY740),
gls1 (CBY1086), erv41 (CBY1168), pep4
(CBY2732), and erv41 pep4 (CBY3306)
strains were compared. (B) Relative amounts
of Gls1 with standard error bars (n = 3). Gls1
levels were normalized with Yet3 as the loading control and plotted as a percentage relative to WT.

such that the level of Erv46 was reduced in an erv41 strain
and Erv41 was not detected in an erv46 strain. Both proteins
contain COPII sorting motifs on their C termini, and Erv46 contains a conserved COPI binding dilysine motif on its C terminus, which cycles the Erv41–Erv46 complex between the ER
and Golgi complex (Otte and Barlowe, 2002). In mammalian
cells, the Erv41–Erv46 complex is distributed between the ER,
ER–Golgi intermediate compartment, and cis-Golgi compartments (Orci et al., 2003; Breuza et al., 2004). Although it has
been shown that yeast strains lacking the Erv41–Erv46 complex are viable and display cold sensitivity, the precise biological function of the Erv41–Erv46 complex is unknown. A study
following in vitro translocation and transport of glyco-pro–
factor in yeast revealed that ER microsomes from an erv41
strain displayed a mild defect in glucose trimming of the attached N-linked core oligosaccharide and produced a similarly
sized product as observed in gls1 microsomes (Welsh et al.,
2006). Glucosidase I (Gls1) cleaves the terminal -1,2–linked
glucose from the newly attached N-linked core glycan and is
thought to function in folding and quality control of nascent
glycoproteins (Moremen et al., 1994; Hitt and Wolf, 2004). In
this study, we investigated the localization of the Gls1 protein in
erv41 strains and observed reduced ER levels coincident with
mislocalization to the vacuole. Whole cell stable isotope labeling by amino acids in culture (SILAC) proteomics identified
other ER proteins that depended on the Erv41–Erv46 complex
for wild-type (WT) expression levels. In combination with biochemical experiments, our findings support a model in which
the Erv41–Erv46 complex functions as a retrograde receptor for
a new class of ER resident proteins.

Results
Deletion of ERV41 mislocalizes Gls1

A previous study indicated a deficiency in Gls1 trimming of
the N-linked core oligosaccharide when the Erv41–Erv46 complex was depleted from cells (Welsh et al., 2006). To further
investigate Erv41–Erv46 function in these cells, we prepared
polyclonal antibodies specific for the Gls1 protein. Gls1 is predicted to have a short cytosolic N terminus (residues 1–10),
a hydrophobic transmembrane domain (residues 11–28), and
a large C-terminal domain (residues 29–833) in the lumen of the
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ER. We purified the luminal domain of Gls1 fused to the C terminus of GST (GST-Gls1) for production of polyclonal serum
against Gls1, and specificity was confirmed by immunoblotting
for Gls1 in WT and gls1 strains (Fig. 1 A). Using anti-Gls1
antiserum, we found that deletion of ERV41 reduced the steadystate cellular levels of Gls1 by 60% compared with the WT
strain (Fig. 1, A and B). Moreover, when pep4 was combined
with erv41, the cellular levels of Gls1 were restored to near
WT levels (Fig. 1, A and B). Because PEP4 encodes proteinase A, a vacuolar aspartyl protease required for processing of
vacuolar precursors, PEP4 deletion leads to the inhibition of
vacuolar protease activity (Ammerer et al., 1986). Carboxypeptidase Y (CPY) is a well-characterized yeast vacuolar enzyme,
which is synthesized and glycosylated at the ER as the proenzyme p1CPY form (67 kD), transported to the Golgi for further
glycosylation to the p2CPY form (69 kD), and then proteolytically processed at the vacuole in a Pep4-dependent manner to
produce the mature CPY (mCPY) form (61 kD; Hemmings
et al., 1981; Stevens et al., 1982). We used CPY maturation as
an indicator for pep4 and note that gls1 shifted mCPY to
a larger size because of the presence of untrimmed glucose residues on the mCPY N-linked carbohydrate. Because Erv41 and
Erv46 form a heteromeric complex and their expression levels
are interdependent (Otte et al., 2001), erv41 and erv46 displayed similar effects on the steady-state cellular levels of Gls1
(Fig. S1), indicating that both Erv41 and Erv46 are required to
maintain cellular levels of Gls1.
Stabilization of Gls1 in erv41 pep4 cells suggested that
Gls1 was transported to vacuoles in the absence of the Erv41–
Erv46 complex. To test for mislocalization of Gls1 to vacuoles
in erv41 cells, we examined the distribution of Gls1 by subcellular fractionation of membranes on sucrose density gradients
(Fig. 2, A–C). In WT and pep4 cells, most Gls1 cosedimented
with the ER marker Yet3 and a smaller fraction with the vacuole
marker CPY (Fig. 2, A and B). In contrast, almost all Gls1 was
colocalized with vacuolar membranes in pep4 erv41 cells
(Fig. 2 C), suggesting that the absence of Erv41 caused mislocalization of Gls1 to vacuoles. We observed that little Gls1
co-migrated with the Golgi marker Ssp120 (Huh et al., 2003) in
both WT and erv41 cells. In addition, we performed immunofluorescence microscopy to examine the localization of Gls1
(Fig. 2 D and Fig. S2). 3HA-tagged Gls1 (HA-Gls1) colocalized

Figure 2. Absence of Erv41 mislocalizes Gls1 to vacuoles. (A–C) Lysates from WT (CBY740; A), pep4 (CBY2732; B), and erv41 pep4 (CBY3306; C)
cells were separated on 18–60% sucrose density gradients. Fractions were collected starting with fraction 1 from the top of the gradient, resolved on 10.5%
polyacrylamide gels, and immunoblotted for Gls1, CPY (vacuole marker), Ssp120 (Golgi marker), and Yet3 (ER marker). The relative amounts of each
protein were determined by densitometry and plotted. The sucrose gradients shown are from a single representative experiment out of two independent repeats of the experiment. (D) Triple HA-tagged Gls1 was visualized by immunofluorescence microscopy using anti-HA monoclonal antibody and anti–mouse
IgG Texas red–conjugated secondary antibody in WT (CBY3841), pep4 (CBY3864), and erv41 pep4 (CBY3867) strains. The same cells were also
stained for Kar2 as an ER marker using polyclonal antibody against Kar2 and anti–rabbit IgG FITC-conjugated secondary antibody. Bars, 5 µm.

with the ER marker Kar2 in WT and pep4 strains, whereas
HA-Gls1 colocalized with the vacuolar marker alkaline phosphatase (ALP) in the pep4 erv41 strain. From these results,
we concluded that the Erv41–Erv46 complex was required for
Gls1 localization to the ER and that Gls1 trimming deficiencies observed in erv41 membranes (Welsh et al., 2006) were
caused by sharp reductions in ER levels of Gls1.
To gain further insight into potential ER retention or retrieval mechanisms that could underlie Gls1 mislocalization in
erv41 cells, we performed in vitro budding assays with ER

microsomes from WT and gls1 strains in the absence or presence of COPII components (Fig. 3). Erv41 and Erv46 were efficiently packaged into COPII vesicles as previously reported
(Otte et al., 2001), and gls1 did not influence these packaging
efficiencies. In WT membranes, Gls1 was not efficiently packaged into COPII vesicles as observed for the ER resident protein
Yet3 (Wilson and Barlowe, 2010). These results indicated that
Gls1 is not actively incorporated into COPII transport vesicles,
although low levels of Gls1 are likely to leak into ER-derived
vesicles. Gls1 dependence on the actively cycling Erv41–Erv46
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Figure 3. Gls1 is not efficiently packaged into COPII vesicles. In vitro budding reactions were performed with microsomes from WT (CBY740) and
gls1 (CBY1086) strains in the absence () or presence (+) of purified COPII
components. Membranes from one tenth of the total reaction (T) and vesicle
fractions were collected by centrifugation, resolved on 10.5% polyacrylamide
gels, and immunoblotted for Gls1, Erv41, and Erv46 as well as the ER resident protein, Yet3, as a negative control.

complex for ER localization is more consistent with a retrieval
mechanism as observed for the dependence of other ER resident
proteins on the cycling KDEL receptor and Rer1 (Lewis and
Pelham, 1990; Sato et al., 1997). Thus, we next explored the
hypothesis that Erv41–Erv46 functions as a retrograde cargo
receptor to retrieve escaped Gls1 back to the ER. In this model,
strains that lack Erv41–Erv46 complex would not retrieve Gls1
from post-ER compartments, resulting in trafficking to the vacuole and degradation.
Erv41–Erv46 complex binds to Gls1
in a pH-dependent manner

Although GLS1 is reported to encode a type II integral membrane protein (Jiang et al., 1996), additional studies show that
a soluble form of Gls1 results from proteolytic cleavage between residues Ala24 and Thr25 near the end of the predicted
transmembrane domain during overexpression and purification
of Gls1 (Dhanawansa et al., 2002). Moreover, this cleavage
site matches a predicted signal sequence cleavage site in Gls1
(Nielsen et al., 1997; Faridmoayer and Scaman, 2004). To examine whether Gls1 is indeed an integral membrane protein or
not, we tested its solubilization properties from ER microsomes
under various conditions (Fig. 4). Gls1 was solubilized and
shifted to the supernatant fraction after treatment with 0.1 M
sodium carbonate, pH 11, or detergent (1% Triton X-100), indicating that Gls1 is an ER luminal protein but does not contain
a transmembrane anchor. In contrast, only detergent treatment
(1% Triton X-100) solubilized the integral membrane proteins
Erv41, Erv46, and Yet3. These results indicate that Gls1 has its
signal sequence cleaved to produce a soluble protein and that
potential sorting information would be contained within this
luminal domain.
To test whether the Erv41–Erv46 complex can bind Gls1
as a cargo, we immobilized the soluble domain of Gls1 fused to
GST (GST-Gls1) on glutathione agarose beads and mixed with
detergent solubilized extracts from microsomes overexpres
sing the Erv41–Erv46 complex. Binding interactions for other
cargo receptors in the early secretory pathway are thought to be
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Figure 4. Gls1 is a soluble ER-luminal protein. Microsomes from WT
(CBY740) cells were incubated in buffer pH 7.0 (20 mM Hepes, pH 7,
150 mM potassium acetate, and 2 mM EDTA), in 1% TX100 (buffer pH
7.0 with 1% Triton X-100), or in buffer pH 11.0 (0.1 M sodium carbonate,
pH 11, and 2 mM EDTA). Total lysates (T) were separated into supernatant (S) and pellet (P) fractions and resolved on 10.5% polyacrylamide
gels and immunoblotted for Gls1, Erv41, Erv46, and Yet3.

regulated by compartmental pH (Wilson et al., 1993; AppenzellerHerzog et al., 2004), and reported pH gradients between the ER
and Golgi range from 7.4 to 6.2 (Paroutis et al., 2004). Therefore, we monitored binding interactions between Gls1 and the
Erv41–Erv46 complex under different pH conditions ranging
from 5.5 to 7.5 (Fig. 5). For these experiments, membrane proteins were solubilized in buffers at the indicated pH followed
by binding to GST-Gls1 and multiple washes at the constant
pH. Bound proteins were eluted from the beads for immuno
blot analysis and revealed that Erv46 bound to GST-Gls1 under
acidic pH buffer conditions (Fig. 5 B). Erv46 did not bind
immobilized GST alone (Fig. 5 A) to support specificity of the
interaction, and Erv41 was not detected in the eluted fractions
under these conditions, suggesting that Gls1 interaction with
the complex was mediated through the Erv46 subunit. These
results are consistent with a model in which the Erv41–Erv46
complex binds to Gls1 in the reduced pH environment of luminal Golgi compartments.
To further explore interactions between the Erv41–Erv46
complex and Gls1, coimmunoprecipitation (IP; co-IP) experiments were performed using detergent-solubilized membrane
extracts from cells expressing different levels and tagged versions of these proteins. In cells overexpressing HA-Erv46 and
Gls1 together, co-IP of Gls1 from Triton X-100–solubilized
membranes across a pH range of 5.5 to 7.5 showed that HAErv46 was recovered in complex with Gls1 (Fig. 6 A). However, equivalent levels of HA-Erv46 were recovered over this
pH range, suggesting that stability of preexisting Gls1-Erv46
complexes was independent of pH. Similarly, in cells overexpressing Erv41, HA-Erv46, and Gls1, co-IP of Gls1 from these
detergent-solubilized membranes recovered both HA-Erv46
and Erv41 across the pH range (Fig. 6 B). These results imply
that a fraction of Gls1 is assembled into complexes with Erv41–
Erv46 under overexpression conditions and that these complexes are insensitive to pH during the co-IP procedure. To
examine why the co-IP assay did not show a pH-dependent interaction, mixing IP assays were performed in which HA-Erv46
and Gls1 were individually overexpressed in cells, membranes
from these cells were solubilized with Triton X-100 in the indicated pH buffers, and then membrane extracts were combined

Figure 5. Erv41–Erv46 complex binds to Gls1 in a pH-dependent manner
in vitro. (A and B) GST (A)- or GST-Gls1 (B)–bound glutathione agarose
beads were incubated with cell lysate from microsomes overexpressing
Erv41–Erv46 complex (CBY978) in different pH buffers (pH 5.5, 6.0, 6.5,
7.0, and 7.5) at 4°C. After washing, proteins bound to the beads were
eluted and resolved on 10.5% polyacrylamide gels and immunoblotted for
Gls1, Erv41, Erv46, Yet3, and GST. (C) Eluted samples were compared
on a single blot for levels of GST-Gls1, Erv46, and GST. Figure panels
were assembled from single immunoblots, and the molecular mass markers
shown indicate relative positions across neighboring strips.

before adding anti-Gls1 antibodies. Under these conditions, HAErv46 coprecipitated with Gls1 in a pH-dependent manner
(Fig. 6 C) and displayed a similar pH profile as observed for
the GST-Gls1 pull-down assay. Based on these collective findings, we speculate that a reduced pH environment promotes
binding of Gls1 to the Erv41–Erv46 complex, although reversal of this interaction is not trigged by pH alone and may depend on additional factors for efficient dissociation.
Proteomic analysis of erv41 and
erv46 mutants identifies additional
Erv41–Erv46 cargo

Because other characterized retrograde and anterograde cargo
receptors in the early secretory pathway are known to recognize multiple cargo proteins (Dancourt and Barlowe, 2010), we
investigated whether other ER resident proteins might depend
on the Erv41–Erv46 complex for retrograde retrieval. Based on
the reduced steady-state protein levels of Gls1 in the erv41
strain, we hypothesized that additional Erv41–Erv46-dependent
cargo proteins would be mistargeted to vacuoles and present at
reduced levels. Advances in mass spectrometry–based quantitative proteomics using SILAC can provide comparative protein
levels for most endogenously expressed proteins in dividing

Figure 6. Erv41–Erv46 complex interacts with Gls1 in vivo. (A and B) Semiintact cells from strains overexpressing HA-Erv46 and Gls1 (CBY3728;
A) or HA-Erv46, Gls1, and Erv41 (CBY3785; B) were solubilized with 1%
Triton X-100 and immunoprecipitated with anti-Gls1 antibody at 4°C in
different pH buffers (pH 5.5, 6.0, 6.5, 7.0, and 7.5). (C) Mixing-IP assay
in which Triton X-100–solubilized lysates from semi-intact cells overexpres
sing HA-Erv46 (CBY770) or Gls1 (CBY3832) were mixed and immunoprecipitated with the anti-Gls1 antibody. Immunoprecipitated proteins were
resolved on 10.5% polyacrylamide gels and immunoblotted for Gls1, HA,
Erv41, and Yet3.

yeast cells (Fröhlich et al., 2013). Through this approach, we
quantified yeast proteome changes in the erv41 and erv46
strains against a WT standard. In total, 3,905 proteins were
identified with relative abundance measurements for 3,494 and
3,486 proteins in the erv41 and the erv46 strain, respectively
(Table S3). In comparing protein abundance changes expressed
as the log2 ratio of deletion strain/WT, we focused on 20 proteins that were significantly reduced (log2 < 0.4) in both the
erv41 and erv46 strains. Importantly, Gls1 was detectably
reduced in the erv41 strain (log2 = 1.19) and the erv46
strain (log2 = 1.40) in accord with our initial observations.
Moreover, Erv41 (log2 = 3.87) and Erv46 (log2 = 4.41)
protein levels were markedly reduced in the respective deletion
strains as expected. A plot of protein intensities against log2 ratios is shown in Fig. 7, with proteins of interest highlighted including Fpr2, Msc1, Vps62, Jem1, and Cpr4. Next, we focused our
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Figure 7. Whole cell proteome changes in
erv41 and erv46 strains using SILAC. Plot
of protein intensities normalized against heavy/
light SILAC ratios of the WT strain (CBY740).
(A and B) Proteome changes in erv41 (CBY1168)
cells with 3,494 proteins quantified (A) and in
erv46 (CBY3612) cells with 3,486 proteins
quantified (B). Proteins of interest that were detected at reduced levels in both deletion strains
are indicated.

attention on potential ER resident proteins that were detected
at reduced steady-state levels as candidate cargo for the Erv41–
Erv46 complex. We obtained strains containing C-terminally
tandem affinity purification (TAP)–tagged Jem1, Vps62, and Fpr2
(Ghaemmaghami et al., 2003), generated erv41::kanR deletions in the TAP-tagged strain background, and monitored their
steady-state expression levels to confirm the proteomic findings.
In our analysis of these strains, significant decreases were detected in Jem1-TAP, Vps62-TAP, and Fpr2-TAP levels in erv41
strains of 49%, 44%, and 94%, respectively, compared with the
WT background (Fig. 8, A and B). These decreases are in good
agreement with the proteomic results.
The yeast FPR2 gene encodes a 15-kD membraneassociated peptidyl-prolyl cis–trans-isomerase that localizes to
the ER and has a predicted N-terminal signal sequence (Nielsen
et al., 1992; Huh et al., 2003). To further examine endogenous
Fpr2 protein levels in WT and erv41 strains, we prepared
polyclonal antiserum specific for Fpr2. Immunoblot analysis
of whole cell extracts demonstrated that erv41 reduced steadystate levels of Fpr2 by 91% compared with the WT strain
(Fig. 8, C and D). Moreover, combining pep4 with erv41
produced a recovery of Fpr2 cellular levels consistent with mislocalization of Fpr2 to vacuolar compartments in the absence of
a functional Erv41–Erv46 complex. Finally, we assessed extracellular secretion of Fpr2 into the growth media because inactivation of Pep4-dependent vacuolar proteases only restored Fpr2
levels to 36% of normal WT cellular levels (Fig. 8, D and E).
Strikingly, both Fpr2 and Gls1 were detected in the extracellular
medium of erv41 and erv41 pep4 strains, indicating that
failure to retain these ER resident proteins in the early secretory
pathway resulted in missorting into both vacuolar-targeted and
exocytic transport vesicles. Based on these results, we conclude
that the Erv41–Erv46 complex is required for localization of
multiple ER resident proteins and propose that the complex
acts as a retrograde receptor to retrieve a subset of escaped
ER proteins.
Mutation of a COPI binding motif in Erv46
mislocalizes Gls1

A previous study has revealed COPI and COPII sorting signals
within the cytoplasmic tail sequences of the Erv41–Erv46 complex that are required to cycle the complex between ER and Golgi
compartments (Otte and Barlowe, 2002). More specifically,
Erv46 contains a conserved dilysine motif on its C-terminal tail,
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which is important for packaging into retrograde-directed COPI
vesicles (Cosson and Letourneur, 1994; Otte and Barlowe, 2002).
It has been reported that mutation of dilysine residues in ER
resident proteins to diarginines disrupts ER retention because
of loss of binding to the COPI complex (Cosson and Letourneur,
1994). To test the model that the Erv41–Erv46 complex functions in retrieval of escaped Gls1, the dilysine motif in Erv46
was mutated to diarginines (Erv46 KK/RR) to block retrograde
transport of the Erv41–Erv46 complex and to monitor the influence on Gls1 localization. By comparing WT Erv46 and Erv46
KK/RR mutant strains (Fig. S3), we found that mutation of the
COPI-binding motif in the Erv46 tail reduced the steady-state
cellular levels of Gls1 by 30% compared with the WT strain.
Moreover, Gls1 was secreted to the extracellular medium in the
Erv46 KK/RR mutant strain. These results indicate that retrograde trafficking of the Erv41–Erv46 complex is important for
retrieval of leaked Gls1. Although mutation of the Erv46 dilysine
motif caused Gls1 mislocalization, we noted that this phenotype
was not as severe as the erv41-null mutation, suggesting that
partially redundant COPI sorting information remained in the
point mutant. Regardless, the impact of this Erv46 dilysine mutation on Gls1 localization supports a retrograde receptor function for the Erv41–Erv46 complex.
Disruption of intracellular pH gradients
causes Gls1 mislocalization

The in vitro pH-dependent interaction between Gls1 and the
Erv41–Erv46 complex led us to investigate its physiological
significance in vivo. The vacuolar ATPase plays an important
role in acidification of vacuoles/lysosomes, endosomes, and
Golgi compartments in eukaryotic cells (Forgac, 2007). The
drug bafilomycin A1 has been shown to be a specific inhibitor
of vacuolar ATPases (Bowman et al., 1988) and to increase the
pH in Golgi compartments (Llopis et al., 1998). To examine the
role of this pH gradient across Golgi membranes in Gls1 localization, we tested the effect of bafilomycin A1 on Gls1 sorting
in vivo. WT yeast cells were treated with 20 µM bafilomycin A1
for 2 h and separated into intracellular and extracellular fractions by centrifugation. We used CPY as a positive control because a previous study demonstrated that bafilomycin A1 caused
missorting and secretion of the vacuolar hydrolase CPY (Banta
et al., 1988). As shown in Fig. 9, Gls1 was secreted into the
extracellular fraction, and the level of secreted p2CPY (Golgi
form of CPY) was increased in the presence of bafilomycin A1,

Figure 8. Deletion of ERV41 reduces cellular levels of Fpr2 caused by vacuolar degradation and extracellular secretion. (A) Fpr2-TAP (CBY3793), Fpr2TAP erv41 (CBY3813), Vps62-TAP (CBY3897), Vps62-TAP erv41 (CBY3908), Jem1-TAP (CBY3791), and Jem1-TAP erv41 (CBY3811) cells grown to
mid–log phase were lysed, resolved on a 10.5% polyacrylamide gel, and immunoblotted for the TAP-tag, Erv41, and Yet3. (B) Relative amounts of Fpr2TAP, Vps62-TAP, and Jem1-TAP with standard error bars (n = 3). TAP-tagged protein levels were normalized with Yet3 as the loading control and plotted
as a percentage relative to WT. (C) Cells grown to mid–log phase were lysed, resolved on 15% polyacrylamide gels, and immunoblotted for Fpr2, CPY,
Erv41, and Yet3 (loading control). WT (CBY740), fpr2 (CBY3758), erv41 (CBY1168), pep4 (CBY2732), and erv41 pep4 (CBY3306) strains
were compared. (D) Relative amounts of Fpr2 with standard error bars (n = 3). Fpr2 levels were normalized with Yet3 as a loading control and plotted
as a percentage relative to WT. (E) Proteins secreted to the extracellular medium were precipitated by TCA, resolved on a 15% polyacrylamide gel, and
immunoblotted for Gls1 and Fpr2.

indicating that the pH gradient across Golgi membranes plays
a role in Gls1 localization. These results provide in vivo evidence
that an intracellular pH gradient regulates binding between escaped ER resident proteins and the Erv41–Erv46 complex for
retrieval back to the ER.

Discussion
Organelle composition in the secretory pathway is maintained
under dynamic cellular conditions through protein targeting,
retention, and retrieval mechanisms. In this study, we describe

a new retrieval activity in which specific ER resident proteins that
have trafficked to Golgi compartments are recognized and returned to the ER by the cycling Erv41–Erv46 retrograde receptor. Our results show that ER resident proteins Gls1 and Fpr2
are secreted or mislocalized in Erv41–Erv46-deficient cells and
that the luminal domain of Gls1 binds directly to the Erv41–
Erv46 complex under mildly acidic conditions. The Erv41–
Erv46 complex is efficiently packaged into ER-derived COPII
vesicles and actively recycles from Golgi compartments to the
ER in COPI vesicles (Otte and Barlowe, 2002). In contrast, ER
resident proteins, such as Gls1, are not efficiently packaged into
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Figure 9. In vivo disturbance of pH gradients by bafilomycin A1 causes
secretion of Gls1. WT (CBY740) cells were incubated for 2 h in the presence or absence of 20 µM bafilomycin A1 (in DMSO). Cultures were separated into intracellular and extracellular fractions. Pellets in the intracellular
fraction were lysed, proteins secreted to the extracellular fraction were
precipitated by TCA, and samples were resolved on a polyacrylamide gel
then immunoblotted for Gls1, CPY, Erv41, and Yet3.

COPII vesicles, and we speculate that a low level of bulk-flow
exit of ER resident proteins must be countered by retrograde
retrieval from early Golgi compartments. If not, escaped ER
resident proteins traffic through the process of Golgi maturation (Losev et al., 2006) followed by Golgi-to-cell surface and
Golgi-to-vacuole transport, which results in protein mislocalization. Pull-down and co-IP experiments indicated that inter
actions between the Erv41–Erv46 complex and Gls1 are regulated
by pH. Moreover, disruption of intracellular pH gradients by
bafilomycin A1 treatment led to secretion of Gls1. Together,
these findings support a model in which escaped Gls1 binds
to Erv41–Erv46 in the reduced pH environment of early Golgi
compartments for retrograde transport and release in the neutral
pH of the ER lumen.
Our model for Erv41–Erv46 activity in retaining ER resident proteins shares parallels with the well-characterized KDEL
receptors that recognize conserved KDEL motifs (HDEL in
yeast) found at the C terminus of many soluble ER resident proteins (Munro and Pelham, 1987; Pelham et al., 1988). The purified human KDEL receptor displays pH-dependent affinity for
KDEL peptides with increased binding activity at an acidic pH
relative to neutral, which is thought to promote KDEL receptor–
ligand interactions in the Golgi complex and release KDEL ligands in the neutral pH of the ER (Scheel and Pelham, 1996).
Interestingly, the pH gradient between ER and Golgi compartments appears to have an opposite effect on anterograde cargo
receptors such as ERGIC53, which binds newly synthesized
glycoproteins in the ER for transport and release in more acidic
Golgi compartments (Appenzeller et al., 1999; AppenzellerHerzog et al., 2004). We observed a similar pH profile for Gls1
binding to Erv41–Erv46 as reported for the interaction between
KDEL receptor and its ligands (Scheel and Pelham, 1996) in
support of the retrograde receptor model. However, we also observed that Gls1 bound to Erv41–Erv46 in detergent-solubilized
membranes extracts was not readily dissociated under reduced pH
conditions, suggesting that additional factors may be required
to facilitate Gls1 release in the ER lumen.
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The Erv41–Erv46 proteins are highly conserved across
species and localize predominantly to the ER–Golgi intermediate compartment and early Golgi compartments as reported
for the KDEL receptors (Orci et al., 2003; Breuza et al., 2004;
Raykhel et al., 2007). ER folding machinery components Gls1,
or glucosidase I (Romero et al., 1997), and the Fpr2 prolylisomerase, or FKBP-13 (Partaledis and Berlin, 1993), are also
conserved, suggesting that this retrieval mechanism is likely to
operate in many cell types. It is important to note that currently
identified Erv41–Erv46 retrieval cargoes are soluble ER-luminal
proteins that do not contain KDEL/HDEL signals, and with the
bulk of the Erv41–Erv46 mass facing the ER lumen, this retrieval
mechanism appears distinct from the seven-transmembrane–
containing KDEL receptor. Moreover, a recent structural study
on the Erv41 luminal domain reveal an unusual -sandwich arrangement and a prominent negative electrostatic surface patch
thought to promote protein–protein interactions (Biterova et al.,
2013), suggesting that the Erv41–Erv46 complex recognizes
a class of ER resident proteins through a novel interaction motif.
We are currently defining this sorting motif in the 118–amino
acid Fpr2 protein, which should permit bioinformatic searches
for other Erv41–Erv46 retrieval cargo. Because certain microbes
are known to express KDEL-bearing pathogenic factors to gain
access to the ER (Sandvig and van Deurs, 2002), identification
of analogous sorting signals for Erv41–Erv46 retrieval may help
explain additional host–pathogen relationships.
Our whole cell SILAC proteomic analysis of deletion
strains provides powerful insights into the consequences of
loss-of-function Erv41–Erv46. Reduced intracellular protein
levels of non-HDEL–bearing ER resident proteins are likely a
result of failures in retrieval that lead to secretion of these proteins from cells or mislocalization and degradation in the vacuole.
Several other notable changes in steady-state levels of secretory
cargo and cytosolic proteins may reflect secondary consequences
of, or cellular responses to, loss of Erv41–Erv46 function. For
example, decreased levels of the plasma membrane transporters
Zrt1/2 and Pdr12 may be caused by loss of specific ER folding
machinery needed for their biogenesis and result in precocious
ER-associated degradation (Kota et al., 2007). Strong reductions
in the proteasome assembly factor Poc4 (Le Tallec et al., 2007)
were observed in both the erv41 and erv46 proteomic datasets.
However, we detected only modest reductions through analy
sis of TAP-tagged Poc4 in the erv41 background, indicating
that further studies will be required to understand this result.
In our initial characterization of the erv41 and erv46
mutants, we observed a modest reduction in apparent fusion of
COPII vesicles with Golgi membrane in cell-free transport reactions (Otte et al., 2001). Based on the current evidence, we
suspect this effect is caused by indirect consequences of the
erv41/erv46 mutations. Reduced levels of ER resident proteins in the mutant cells may result in inefficient ER export of
proteins necessary for fusion at Golgi membranes or for glycosylation of glyco-pro–-factor that serves as the readout for
fusion in cell-free assays (Baker et al., 1988). Interestingly, it was
recently reported that the Golgi-localized mannosyltransferase
Ktr4 accumulates in the ER of erv41 and erv46 strains (Noda
et al., 2014), which could explain reduced levels of Golgi-modified

Table 1. Yeast strains used in this study
Strain
CBY80 (=FY834)
CBY740 (=BY4742)
CBY742 (=BY4741)
CBY770
CBY978
CBY1086
CBY1168
CBY2732
CBY3306
CBY3561
CBY3612
CBY3728
CBY3758
CBY3785
CBY3791
CBY3793
CBY3811
CBY3813
CBY3832
CBY3841
CBY3854
CBY3855
CBY3864
CBY3867
CBY3897
CBY3908
CBY4002
CBY4003
CBY4004

Genotype

Reference

MAT his3-200 ura3-52 leu2-1 lys2-202 trp1-63
MAT his31 leu20 lys20 ura30
MATa his31 leu20 met150 ura30
CBY80 with ERV46::HISMX6-PGAL1-3HA
CBY80 containing pRS424-ERV41 and pRS426-ERV46
CBY740 with gls1::kanR
CBY740 with erv41::kanR
CBY740 with pep4::kanR
CBY740 with erv41::HIS3 pep4::kanR
CBY740 containing pYEX4T-1-GLS1
CBY740 with erv46::kanR
CBY80 with ERV46::HISMX6-PGAL1-3HA containing pRS425-GLS1
CBY740 with fpr2::kanR
CBY80 with ERV46::HISMX6-PGAL1-3HA containing pRS424-ERV41 and pRS425-GLS1
CBY742 with JEM1::HIS3MX6-TAP
CBY742 with FPR2::HIS3MX6-TAP
CBY742 with JEM1::HIS3MX6-TAP erv41::kanR
CBY742 with FPR2::HIS3MX6-TAP erv41::kanR
CBY80 containing pRS425-GLS1
CBY740 with gls1::kanR containing pRS317-HA-GLS1
CBY740 with pep4::kanR gls1::natR
CBY740 with erv41::HIS3 pep4::kanR gls1::natR
CBY740 with pep4::kanR gls1::natR containing pRS317-HA-GLS1
CBY740 with erv41::HIS3 pep4::kanR gls1::natR containing pRS317-HA-GLS1
CBY742 with VPS62::HIS3MX6-TAP
CBY742 with VPS62::HIS3MX6-TAP erv41::kanR
CBY740 with erv46::kanR containing pRS316
CBY740 with erv46::kanR containing pRS316-ERV46
CBY740 with erv46::kanR containing pRS316-ERV46(KK/RR)

glyco-pro–-factor in our fusion assays. It is also possible that
some cellular changes are caused by Erv41–Erv46 function as
an anterograde cargo receptor for specific proteins as proposed
for Golgi localization of Ktr4 (Noda et al., 2014). However, we
note that the erv41 and erv46 strains do not display an activated unfolded protein response as reported for other anterograde cargo receptor deletion strains (Jonikas et al., 2009).
Finally, observed increases in cell surface proteins (e.g.,
Tos1 and Ecm25) and transcription regulatory machinery (e.g.,
Ngg1 and Sap30) may reflect cellular responses to perturbation of the ER luminal environment. Further analyses will be
required to confirm the magnitude of these increases. Regardless, the global snapshot provided by whole cell proteomics
suggests clear models that can be tested through SILAC and experimental analyses of available yeast mutant strains to more
fully define the cellular function of Erv41–Erv46.

Materials and methods
Yeast strains and growth media
Yeast strains used in this study are listed in Table 1. Strains were grown at
30°C in rich medium (YPD [1% Bacto yeast extract, 2% Bacto-peptone,
and 2% glucose]). Growth of cell cultures was monitored by absorbance
(OD) at 600 nm (OD600). Precultures were grown overnight in YPD to stationary phase, and fresh YPD was inoculated with precultures to an OD600
of 0.1. Cells were grown at 30°C and harvested in mid–log phase between 0.8 and 1.2 OD600. Yeast strains containing plasmids were grown

Winston et al., 1995
Winzeler et al., 1999
Winzeler et al., 1999
Otte et al., 2001
Otte et al., 2001
Winzeler et al., 1999
Winzeler et al., 1999
Winzeler et al., 1999
This study
This study
This study
This study
Winzeler et al., 1999
This study
Ghaemmaghami et al., 2003
Ghaemmaghami et al., 2003
This study
This study
This study
This study
This study
This study
This study
This study
Ghaemmaghami et al., 2003
This study
This study
This study
This study

overnight in minimal medium (YMD [0.7% yeast nitrogen base without
amino acids, 2% glucose, and the appropriate supplement mixture (complete
supplement mixture; MP Biomedicals)]) and back diluted into YPD medium.
For overexpression from the GAL1 promoter, cells were grown overnight in
YPD or YMD containing 1% galactose and 1% glucose and back diluted to
YPD containing 1.5% galactose and 0.5% glucose. For overexpression
from the Cu2+-inducible CUP1 promoter in plasmid pYEX4T-1-Gls1, GSTGls1 expression was induced by the addition of 0.5 mM copper sulfate.
Plasmid construction
Plasmids and primers used in this study are listed in Tables S1 and S2. Genomic DNA from CBY740 was used as the template for PCR amplification
and cloning. The DNA sequences of GLS1 (YGL027C), ERV46 (YAL042W),
and FPR2 (YDR519W) were obtained from the Saccharomyces Genome
Database. For overexpression of GST-Gls1 in yeast, the GLS1 sequence
encoding amino acids 33–833 was amplified by PCR using primers GLS1EcoRI and GLS1–SalI-1. The PCR product was ligated into the EcoRI and
SalI restriction sites of the pYEX4T-1-ERV46 plasmid (obtained from Research
Genetics; Macreadie et al., 1991; Ward et al., 1994) to generate plasmid
pYEX4T-1–GLS1. To construct pRS425-GLS1 and pRS317-GLS1, GLS1 and
300 bp of its flanking upstream and downstream sequences were amplified using primers GLS1-NotI and GLS1–SalI-2 and ligated into the NotI
and SalI restriction sites of pRS425 (Christianson et al., 1992) and pRS317
(Eriksson et al., 2004). The correct GLS1 sequences were verified by DNA
sequencing using primers GLS1-SalI-1, GLS1-NotI, GLS1-SalI-2, GLS1-XhoI,
GLS1-IntF, and GLS1-IntR. The plasmid pRS317-HA-GLS1 was constructed
as previously described (Jiang et al., 1996). The triple HA epitope tag was
inserted into the unique EcoRI site located between codons 24 and 25 of
GLS1 in plasmid pRS317-GLS1.
For overexpression of Fpr2 fused to the C terminus of GST (GST-Fpr2)
in Escherichia coli, the FPR2 sequence encoding amino acids 18–135 was
amplified by PCR using primers FPR2-BamHI and FPR2-EcoRI. The PCR
product was ligated into the BamHI and EcoRI restriction site of the pGEX2T
plasmid (GE Healthcare) to generate plasmid pGEX2T-FPR2.
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To convert the Erv46 lysine residues in positions 412 and 413 to arginine residues, ERV46 and 300 bp of upstream sequence were amplified using pRS316-ERV46 as a template for primers YAL042w-NotI and
ERV46(KK/RR)-R followed by gel purification (QIAGEN). Next, ERV46 and
300 bp of the downstream sequence were amplified using pRS316-ERV46
and the primers YAL042w-BamHI and ERV46(KK/RR)-F followed by gel purification. Both gel-purified PCR products were then mixed and used as the
template to amplify ERV46 containing the point mutations using primers
YAL042w-NotI and YAL042w-BamHI. This PCR product was ligated into the
NotI and BamHI restriction site of pRS316 (Sikorski and Hieter, 1989) to obtain plasmid pRS316-ERV46(KK/RR). The correct ERV46 sequences were
verified by DNA sequencing using primers YAL042w-NotI, YAL042w-BamHI,
ERV46-IntF, and ERV46-IntR.
Strain construction
To generate the erv41 pep4 double knockout strain (CBY3306), ERV41
in the pep4 strain (CBY2732) was targeted for gene disruption with the
HIS3 gene using plasmid pFA6a-His3MX6 and primers Erv41-KO-F and
Erv41-KO-R (Longtine et al., 1998). To generate the erv46 strain (CBY3612),
ERV46 in the WT strain (CBY740) was targeted for gene disruption with the
kanamycin-resistance (kanR) gene using plasmid pFA6a-kanMX6 and primers Erv46-KO-F and Erv46-KO-R (Longtine et al., 1998). For CBY3854 and
CBY3855, GLS1 in the pep4 strain (CBY2732) and the erv41 pep4
strain (CBY3306) was deleted with the nourseothricin-resistance (natR) gene
using plasmid pFA6a-natMX6 and primers Gls1-KO-F and Gls1-KO-R (Hentges
et al., 2005). All strains with C-terminally TAP-tagged ORFs were purchased
from Thermo Fisher Scientific, and ERV41 in these strains was deleted with
the kanR gene using plasmid pFA6a-kanMX6 and primers Erv41-KO-F and
Erv41-KO-R (Longtine et al., 1998). All yeast transformations were performed
using the lithium acetate technique (Elble, 1992).
Antibodies and immunoblotting
Rabbit polyclonal antiserum against Erv41 and Erv46 (Otte et al., 2001),
CPY (Rothblatt et al., 1989), Kar2 (Brodsky and Schekman, 1993), ALP
(Haas et al., 1995), Erv26 (Bue et al., 2006), and Yet3 (Wilson and Barlowe,
2010) have been described previously. Anti-Erv26p and anti-Yet3 rabbit
antibodies were raised against GST fusion proteins and used for detection
of GST where indicated. Polyclonal antiserum against Fpr2 was raised in
rabbits using purified GST-Fpr2 as the antigen (Thermo Fisher Scientific).
GST-Fpr2 was expressed in DH5 cells, lysed, and purified by glutathioneagarose chromatography as described by the manufacturer (GE Healthcare). Polyclonal antiserum for Ssp120 was raised in rabbits using purified
6×His-tagged Ssp120 expressed from the pET15b plasmid (EMD Millipore) as an antigen. Sheep anti–mouse and donkey anti–rabbit secondary
horseradish peroxidase–linked antibodies were purchased from GE Healthcare, and mouse monoclonal antibodies against HA (HA.11) were obtained
from Covance. All primary antibodies were used at a 1:1,000 dilution
except for CPY (1:1,500 dilution), and secondary antibodies were at a
1:20,000 dilution. Chemiluminescence from immunoblots was enhanced
with SuperSignal West Pico Chemiluminescent substrate (Thermo Fisher Scientific) or Luminata Crescendo Western HRP substrate (EMD Millipore) and
detected using a G:BOX Chemi XR5 (Syngene). For densitometric analysis,
captured images of immunoblots were quantified with GeneTools image
analysis software (Syngene).
Polyclonal antiserum against Gls1 was raised in rabbits using purified GST-Gls1 as an antigen (Covance). To prepare GST-Gls1, yeast cells
containing pYEX4T-1–GLS1 (CBY3561) were precultured in YMD containing complete supplement mixture–URA and back diluted into 7.5 liters of
YPD. Cells were grown to 0.5 OD600, and copper sulfate was added
to a final concentration of 0.5 mM. After induction for 3 h, cells were
harvested and washed with TBS (50 mM Tris/Cl, pH 7.4, and 150 mM
NaCl). Cell pellets were resuspended to 1.8 g/ml in TBS and frozen into
cell beads by dripping into liquid nitrogen. Cells were lysed in liquid nitrogen using a Waring blender to mix the beads for 2 min to obtain a fine
cell powder. The cell powder was resuspended in 175 ml of TBS containing 1 mM PMSF and 1 mM DTT and centrifuged for 5 min at 4°C in rotor
(SS-34; Sorvall) at 3,500 rpm. The resulting supernatant fraction was then
centrifuged for 30 min at 4°C in SS-34 rotor at 15,000 rpm. This supernatant was then applied to a Q Sepharose (GE Healthcare) column (2.5 ×
10 cm; Bio-Rad Laboratories) that contained a 70-ml packed bed volume
using a fast protein liquid chromatography system (AKTA; GE Healthcare).
After washing with TBS, the GST-Gls1 protein was eluted with a 250-ml
continuous buffer gradient from 150 mM to 0.5 M NaCl. The fractions
containing GST-Gls1 were monitored by Western blotting using GST-Erv26
antiserum for detection of GST-tagged proteins, and peak fractions were
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combined to obtain 50 ml of semipurified GST-Gls1. This fraction was
mixed with 5 ml of glutathione-agarose (Sigma-Aldrich) for 1 h with rotation at 4°C and then applied into a 1.5 × 10–cm column followed by
wash with TBS and elution with TBS containing 10 mM glutathione. The
fractions containing highly purified GST-Gls1 protein were determined by
Coomassie blue–stained polyacrylamide gels and pooled to yield 3 ml of
0.8 mg/ml protein.
Membrane preparations and subcellular fractionation
Yeast semi-intact cells were prepared as previously described (Baker et al.,
1988) with minor modification as follows. Cells were grown to the mid–log
phase, harvested by centrifugation at 5,000 rpm for 5 min at room temperature in a rotor (GS-3; Sorvall), and resuspended in Tris/DTT buffer
(100 mM Tris-HCl, pH 9.4, and 10 mM DTT). After incubation at room
temperature for 10 min, cells were harvested by centrifugation, resuspended
in lyticase buffer (20 mM Tris-HCl, pH 7.5, 0.7 M sorbitol, 0.5% glucose,
2 mM DTT, and lyticase), and incubated for 15 min at room temperature
until the OD600 decreased to <20% of the initial value. Spheroplasted cells
were harvested by centrifugation at 5,000 rpm for 10 min at 4°C in an SS-34
rotor and resuspended at 75 OD280 U/ml in semi-intact cells lysis buffer
(20 mM Hepes, pH 7.0, 0.4 M sorbitol, 150 mM KOAc, and 2 mM MgOAc)
at 4°C. 100-µl aliquots of this spheroplast suspension were transferred to
tubes, frozen in liquid N2, and stored at 80°C.
Yeast ER microsomes were prepared as previously described
(Wuestehube and Schekman, 1992) with modifications as follows. Spheroplasted cells as prepared in the previous paragraph were resuspended
in JR lysis buffer (20 mM Hepes, pH 7.4, 0.1 M sorbitol, 50 mM KOAc,
2 mM EDTA, 1 mM PMSF, and 1 mM DTT) and homogenized with 10
strokes of a chilled-glass Potter–Elvehjem homogenizer. Homogenates were
centrifuged for 5 min at 4°C in an SS-34 rotor at 3,500 rpm. This supernatant fraction was then centrifuged for 10 min at 4°C in an SS-34 rotor at
15,000 rpm. The resulting membrane pellets were resuspended in JR lysis
buffer and loaded on top of a 1.2 M/1.5 M sucrose step gradient. Gradients were spun at 40,000 rpm for 1 h in a rotor (SW-60; Beckman Coulter)
at 4°C. The microsome band that sedimented to the 1.2 M/1.5 M sucrose interface was collected and washed with B88 buffer (20 mM Hepes,
pH 6.8, 250 mM sorbitol, 150 mM KOAc, and 5 mM MgOAc) by centrifugation at 15,000 rpm for 10 min at 4°C in an SS-34 rotor. The final microsome pellet was resuspended at 16 OD280 U/ml in B88 buffer at 4°C.
100-µl aliquots were transferred to plastic tubes, frozen in liquid N2, and
stored at 80°C.
For subcellular fraction of membranes, whole cell lysates were resolved on sucrose density gradients as described previously (Powers and
Barlowe, 1998) with minor modifications as follows. Spheroplasted cells
were resuspended in lysis buffer (10 mM Hepes, pH 7.4, 12.5% sucrose,
1 mM EDTA, and 0.5 mM PMSF) and homogenized with 10 strokes of a
chilled-glass Potter–Elvehjem homogenizer. The homogenates were centrifuged for 5 min at 4°C in an SS-34 rotor at 3,500 rpm. The supernatant
fraction was loaded onto the top of a sucrose step gradient. For preparing
sucrose gradients, 1 ml of 60% sucrose was placed at the bottom of an
ultracentrifuge tube (SW-40; Beckman Coulter) and overlaid with 0.75-ml
steps of sucrose from 54% to 18% (54, 50, 46, 42, 38, 34, 30, 26, 22,
and 18%) in Hepes buffer (10 mM Hepes, pH 7.4, and 1 mM MgCl2). Gradients were centrifuged at 4°C for 3 h in an SW-40 rotor at 36,000 rpm,
and 0.75-ml fractions were collected from the top of the gradient. Fractions
were diluted 1:1 in SDS-PAGE sample buffer, heated at 75°C for 5 min,
resolved on 10.5% polyacrylamide gels, and immunoblotted for Gls1, CPY,
Ssp120, and Yet3.
To determine whether Gls1 is an integral membrane protein, fractionation and solubilization procedures were performed as previously described (Otte et al., 2001) using microsomes from the WT strain (CBY740).
Microsomes were suspended in buffer pH 7.0 (20 mM Hepes, pH 7,
150 mM KOAc, and 2 mM EDTA), in buffer pH 7.0 with 1% Triton X-100,
or in buffer pH 11.0 (0.1 M sodium carbonate, pH 11, and 2 mM EDTA)
and incubated on ice for 10 min. After centrifugation at 60,000 rpm in a
rotor (TLA100.3; Beckman Coulter), equivalent amounts of the total, supernatant, and pellet fractions were resolved on 10.5% polyacrylamide gels
and immunoblotted for Gls1, Erv41, Erv46, and Yet3.
In vitro assays
In vitro COPII budding assays were performed by incubation of ER microsomes in the presence or absence of purified COPII proteins (Sar1, Sec2324, and Sec13-31) at 25°C for 20 min as previously described (Barlowe
et al., 1994). After centrifugation of these reactions at 14,000 rpm in a
rotor (FA45-30-11; Eppendorf) to pellet ER membranes, budded vesicles

in the supernatant fraction were collected by centrifugation in a TLA100.3
at 55,000 rpm for 12 min. The resulting total and vesicle pellet fractions
were heated at 75°C for 5 min in 35 µl of SDS-PAGE buffer, resolved on
10.5% polyacrylamide gels, and immunoblotted for Gls1, Erv41, Erv46,
and Yet3.
For GST pull-down assays, fast protein liquid chromatography–
purified GST-Gls1 and bacterially expressed GST from plasmid pGEX-2T
(GE Healthcare) were immobilized on glutathione-agarose beads. First,
100 µl of glutathione-agarose beads (50% vol/vol; Sigma-Aldrich) were
washed twice with 1 ml of TBS by centrifugation at 4°C for 1 min in a rotor
(FA45-30-11) at 14,000 rpm. The washed glutathione-agarose beads
were incubated with 1 ml of purified GST proteins (0.1 mg/ml) and
incubated at 4°C for 2 h with rotation. After incubation, the beads were
washed twice with 1 ml of TBS and washed once with 1 ml of PD buffer
(pH 5.5, 6.0, and 6.5; 50 mM MES and 150 mM NaCl, pH 7.0 and
7.5; and 50 mM Tris-HCl and 150 mM NaCl). Microsomes (100 µl of
16 OD280U/ml) were solubilized with 1% Triton X-100 in 1 ml of each PD
buffer containing 1 mM PMSF on ice for 10 min and centrifuged for 5 min
at 14,000 rpm in a FA45-30-11 rotor at 4°C. The supernatants were incubated with GST-bound glutathione-agarose beads at 4°C overnight with
rotation. Agarose beads were centrifuged at 4°C for 1 min in a FA45-30-11
rotor at 14,000 rpm, washed twice with 1 ml of each PD buffer containing
1% Triton X-100, eluted with 50 µl of SDS-PAGE buffer, and resolved on
10.5% polyacrylamide gels. To compare the GST protein levels bound to
the agarose, eluted samples were immunoblotted on a single blot using
GST-Yet3 antiserum for detection of GST and GST-Gls1 proteins.
IP assay
Protein A Dynabeads (Novex) were washed with 1 ml of IP buffer (pH 5.5,
6.0, and 6.5; 50 mM MES and 150 mM NaCl, pH 7.0 and 7.5; and
50 mM Tris-HCl and 150 mM NaCl). Dynabeads (30 µl of 30 mg/ml)
were incubated with 1 µl of anti-Gls1 antiserum for 20 min at room temperature with rotation followed by washing with 1 ml of IP buffer. To prepare
membrane extracts, 0.1 ml of semi-intact cells (75 OD280U/ml) were solubilized with 1% Triton X-100 in 1 ml of IP buffer containing 1 mM PMSF
for 10 min on ice followed by a centrifugation for 5 min at 14,000 rpm in
a FA45-30-11 rotor at 4°C. The supernatants were mixed with antibodybound Dynabeads and incubated for 5 h at 4°C with rotation. The beads
were washed five times with cold IP buffer, eluted by heating at 75°C for
5 min in 30 µl of SDS-PAGE sample buffer, and resolved on 10.5% polyacrylamide gels. For mixing-IP assays, 0.1-ml semi-intact cells were solubilized with 1% Triton X-100 in 0.5 ml of IP buffer containing 1 mM PMSF.
The supernatants from solubilized semi-intact cells were combined just before mixing with the antibody-bound Dynabeads.
Indirect immunofluorescence microscopy
For indirect immunofluorescence microscopy as previously described (Powers
and Barlowe, 1998), formaldehyde-fixed yeast cells were converted to
spheroplasts and adhered to polylysine-coated slides. Cells were washed
and incubated at room temperature in blocking buffer (1% BSA and 0.5%
Triton X-100 in phosphate-buffered saline) followed by development with
primary antibodies. The anti-HA monoclonal antibody (HA.11) was used at
1:200 dilution. Polyclonal sera against Kar2 and ALP were used at 1:400
and 1:200, respectively. Secondary fluorescein-conjugated anti–rabbit IgG
and Texas red–conjugated anti–mouse IgG antibodies were obtained from
Vector Laboratories and used at 1:200. Images were obtained at room
temperature using a DeltaVision Imaging System (Applied Precision), comprising a customized inverted wide-field microscope (IX-71; Olympus),
an UPlanS Apochromat 100×/1.40 NA lens (Olympus) with DeltaVision
immersion oil (n = 1.516; GE Healthcare), a camera (CoolSNAP HQ2;
Photometrics), and an Insight solid-state illumination unit. Images were processed by deconvolution in SoftWoRx (Applied Precision) and prepared
with Photoshop (Adobe) and ImageJ (National Institutes of Health).
Mass spectrometry–based quantitative proteomics
To determine protein abundance fold changes, WT (BY4742) and isogenic erv41 (CBY1168) and erv46 (CBY3612) strains were compared
in SILAC experiments following the protocol described in Fröhlich et al.
(2013). In brief, cell labeling was conducted in synthetic medium at 30°C.
Equal amounts (40 OD600 units) of light-labeled control and heavy-labeled
mutant cells (erv41 and erv46) were mixed before cell lysis. Cells were
lysed in buffer containing 50 mM Tris-HCl, pH 9.0, 5% SDS, and 100 mM
DTT for 30 min at 55°C. Lysates were cleared by centrifugation at 17,000 g
for 10 min. Supernatants were diluted with buffer UA (8 M urea and 0.1 M
Tris-HCl, pH 8.5) to a final concentration of 0.5% SDS. Proteins were

digested with the endoproteinase LysC by filter-aided sample preparation.
Peptides were recovered in 0.5 M NaCl, acidified by the addition of trifluor
oacetic acid, and cleared of precipitates via centrifugation at 17,000 g for
5 min. Peptides (5 µg) were desalted and injected into the high-performance
liquid chromatography. Reversed-phase chromatography was performed
on a liquid chromatograph system (EASY-nLC 1000; Thermo Fisher Scientific)
connected to a mass spectrometer (Q Exactive; Thermo Fisher Scientific)
through a nano-electrospray ion source. Eluted peptides from the column
were directly electrosprayed into the mass spectrometer. Mass spectra
were acquired on the Q Exactive in a data-dependent mode to automatically switch between full scan mass spectrometry and ≤10 data-dependent
tandem mass spectrometry scans. The resulting mass spectrometry and
tandem mass spectrometry spectra were analyzed using MaxQuant (version 1.3.0.5), using its integrated Andromeda search algorithms. Triplicate
liquid chromatography runs coupled to mass spectrometry were performed
for independent biological duplicates. Data analysis was performed, and
significance values were determined as previously described (Fröhlich
et al., 2013).
Fpr2 and Gls1 secretion
Extracellular secretion of proteins was analyzed as previously described
(Belden and Barlowe, 2001). In brief, cells were precultured in YPD or
complete synthetic media and back diluted in YPD to an OD600 of 0.15,
and cultures were grown to an OD600 of 0.8. Cultures were then centrifuged at 14,000 rpm, and proteins contained in the supernatant fraction
(1.3 ml) were precipitated by addition of TCA to a final concentration of
10%. TCA-precipitated proteins were collected by centrifugation, washed
with 96% ethanol, resolved on 15% polyacrylamide gels, and immunoblotted
for Gls1, Erv41, Yet3, and Fpr2.
Bafilomycin A1 treatment
WT (CBY740) cells were grown in YPD to 0.5 OD600, and 2 mM bafilomycin A1 in DMSO was added to a final concentration of 20 µM. After
treatment for 2 h, cells were harvested and separated into intracellular and
extracellular fractions. Pellets in the intracellular fraction were lysed, and
proteins secreted to the extracellular fraction were precipitated by TCA as
described in the previous section.
Online supplemental material
Fig. S1 shows that the erv46 mutation reduces cellular levels of Gls1
similarly to erv41 and is consistent with a functional requirement for both
subunits of the Erv41–Erv46 complex. Fig. S2 indicates that the absence
of Erv41 causes mislocalization of Gls1 to vacuoles by visualizing HAGls1 colocalized with the vacuolar marker ALP in an immunofluorescence
microscopy experiment. Fig. S3 shows that mutation of a C-terminal COPI
binding motif in Erv46 causes Gls1 mislocalization. Table S1 lists the plasmids used in this study. Table S2 lists primers used in this study. Table S3
provides the mass spectrometry peptide data for the erv41 and erv46
strains from SILAC experiments and proteome changes sorted from smallest to largest log2 (erv41/control) scores and is provided online in an
Excel (Microsoft) spreadsheet. Online supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.201408024/DC1.
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